Clinica Baviera (0GWJ) Price & Analysis

Compare

0 Followers

0GWJ Stock Chart & Stats

€46.80

€0.40(1.22%)

At close: Jan 08 4:00 PM EST

€46.80

€0.40(1.22%)

Day’s Range― - ―

52-Week Range€29.80 - €55.60

Previous CloseN/A

Volume1.00

Average Volume (3M)44.00

Market Cap

€828.22M

Enterprise Value€829.77M

Total Cash (Recent Filing)€50.32M

Total Debt (Recent Filing)€69.16M

Price to Earnings (P/E)30.7

Beta0.64

Next Earnings

Jul 28, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.81

Shares Outstanding16,307,580

10 Day Avg. Volume57

30 Day Avg. Volume44

Financial Highlights & Ratios

PEG Ratio8.17

Price to Book (P/B)8.37

Price to Sales (P/S)2.75

P/FCF Ratio17.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.86

Revenue Forecast (FY)€323.25M

Bulls Say, Bears Say

Bulls Say

Specialized Clinic NetworkClinica Baviera's focused network model centers on elective refractive and broader ophthalmic services, producing fee-based revenues across diagnosis, surgery and follow-up care. That patient-pathway capture supports durable per-patient revenue, cross-selling and stable clinic utilization over time.

Consistent Multi-year GrowthSustained revenue and earnings expansion over multiple years (2021–2025) demonstrates persistent market demand and operational scalability. This trend supports reinvestment in capacity and services and provides a stronger baseline for forecasting medium-term cash flows and margin sustainability.

Solid Operating Cash GenerationConsistently positive operating cash flow—often above reported net income—indicates high earnings quality and reliable internal funding. Persistent cash generation underpins capacity to fund capex, service debt, and support dividends or share buybacks without immediate external financing in normal conditions.

Bears Say

Rising Debt TrendAn uptick in leverage into 2024–2025 reduces financial flexibility and raises sensitivity to slower growth or higher rates. Higher debt servicing obligations can limit discretionary investment, increase refinancing risk, and constrain strategic options if operating performance weakens over the next several quarters.

Free Cash Flow VolatilityVolatile free cash flow and a sharp 2025 drop—despite solid operating cash flow—suggest rising capex or working-capital needs. That variability can strain payout capacity and may force external funding for growth or operations, increasing financing cost risk and limiting stable shareholder returns.

Slower Growth And Margin AnomalyA slowdown in 2025 growth combined with an anomalous 2024 gross-profit spike raises questions on sustainability of margins. If part of prior margin strength was one-off, forward earnings and margin forecasts become less reliable, increasing execution risk for medium-term profitability targets.

Clinica Baviera News

Clínica Baviera Shareholders Approve Key Proposals at General Meeting

The latest update is out from Clinica Baviera ( ($ES:CBAV) ). The Ordinary General Meeting of Shareholders of...

9M ago

Clínica Baviera Appoints New Vice Presidents to Board

Clinica Baviera ( ($ES:CBAV) ) has provided an update. Clínica Baviera has announced the appointment of Ms. Yongmei...

9M ago

Clinica Baviera Proposes New Director Remuneration Policy for 2025-2028

Clinica Baviera ( ($ES:CBAV) ) just unveiled an update. Clinica Baviera, S.A. has announced its remuneration policy for...

10M ago

Clínica Baviera Announces Ordinary General Meeting of Shareholders

Clinica Baviera ( ($ES:CBAV) ) has shared an update. Clínica Baviera’s Board of Directors has announced the convening...

11M ago

Clinica Baviera Announces 2024 Dividend Details

Clinica Baviera ( ($ES:CBAV) ) has provided an announcement. Clinica Baviera has announced the details of its upcoming...

11M ago

Clínica Baviera Share Sale Targets Qualified Investors

Clinica Baviera ( ($ES:CBAV) ) has issued an update. Aier Eye International (Europe), S.L.U. and Vito Gestión Patrimonial,...

11M ago

Clínica Baviera Share Sale Targeting Qualified Investors

Clinica Baviera ( ($ES:CBAV) ) just unveiled an announcement. Aier Eye International (Europe) and Vito Gestión Patrimonial are...

11M ago

Clinica Baviera Proposes 2024 Dividend Distribution

An update from Clinica Baviera ( ($ES:CBAV) ) is now available. The Board of Directors of Clinica Baviera...

11M ago

Clinica Baviera Reports 2024 Liquidity Operations

Clinica Baviera (ES:CBAV) has released an update. Clinica Baviera has reported its liquidity contract operations for the last...

1y ago

Clínica Baviera Appoints New Director and Audit Chair

Clinica Baviera (ES:CBAV) has released an update. Clínica Baviera has appointed Carolina Martínez-Caro as a new independent director,...

1y ago

0GWJ FAQ

What was Clinica Baviera, SA’s price range in the past 12 months?

Clinica Baviera, SA lowest share price was €29.80 and its highest was €55.60 in the past 12 months.

What is Clinica Baviera, SA’s market cap?

Clinica Baviera, SA’s market cap is €828.22M.

When is Clinica Baviera, SA’s upcoming earnings report date?

Clinica Baviera, SA’s upcoming earnings report date is Jul 28, 2026 which is in 143 days.

How were Clinica Baviera, SA’s earnings last quarter?

Clinica Baviera, SA released its earnings results on Mar 04, 2026. The company reported €0.813 earnings per share for the quarter, beating the consensus estimate of N/A by €0.813.

Is Clinica Baviera, SA overvalued?

According to Wall Street analysts Clinica Baviera, SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Clinica Baviera, SA pay dividends?

Clinica Baviera, SA does not currently pay dividends.

What is Clinica Baviera, SA’s EPS estimate?

Clinica Baviera, SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Clinica Baviera, SA have?

Clinica Baviera, SA has 16,307,580 shares outstanding.

What happened to Clinica Baviera, SA’s price movement after its last earnings report?

Clinica Baviera, SA reported an EPS of €0.813 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.789%.

Which hedge fund is a major shareholder of Clinica Baviera, SA?

Currently, no hedge funds are holding shares in GB:0GWJ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Clinica Baviera, SA

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.